ENSIGN GROUP, INC (ENSG) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 1.03%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 1.03% | Share-based compensation / revenue. Period ending 2026-06-30. $55.97M ÷ $5.46B × 100 ≈ 1.03% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 5.46B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 55.97M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 467.39M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $5.46B | $55.97M | $467.39M | (m) | (m) | 1.03% | (m) | (m) |
| 2026-03-31 | (m) | $5.25B | $51.47M | $448.79M | (m) | (m) | 0.98% | (m) | (m) |
| 2025-12-31 | (m) | $5.03B | $48.30M | $425.31M | (m) | (m) | 0.96% | (m) | (m) |
| 2025-09-30 | (m) | $4.83B | $45.20M | $402.27M | (m) | (m) | 0.94% | (m) | (m) |
| 2025-06-30 | (m) | $4.61B | $41.39M | $395.39M | (m) | (m) | 0.90% | (m) | (m) |
| 2025-03-31 | (m) | $4.42B | $38.71M | $377.46M | (m) | (m) | 0.88% | (m) | (m) |
| 2024-12-31 | (m) | $4.26B | $36.23M | $358.30M | (m) | (m) | 0.85% | (m) | (m) |
| 2024-09-30 | (m) | $4.11B | $34.48M | $280.35M | (m) | (m) | 0.84% | (m) | (m) |
| 2024-06-30 | (m) | $3.97B | $32.53M | $270.81M | (m) | (m) | 0.82% | (m) | (m) |
| 2024-03-31 | (m) | $3.85B | $32.43M | $262.71M | $8.02M | (m) | 0.84% | 32.78× | Reported |
| 2023-12-31 | (m) | $3.73B | $30.77M | $255.37M | $8.09M | (m) | 0.82% | 31.58× | Reported |
| 2023-09-30 | (m) | $3.54B | $28.73M | $307.74M | $8.15M | (m) | 0.81% | 37.76× | Reported |
| 2023-06-30 | (m) | $3.37B | $27.39M | $302.23M | $8.23M | (m) | 0.81% | 36.71× | Reported |
| 2023-03-31 | (m) | $3.18B | $24.13M | $302.59M | $8.90M | (m) | 0.76% | 34.00× | Reported |
| 2022-12-31 | (m) | $3.01B | $22.72M | $296.82M | $8.93M | (m) | 0.76% | 33.24× | Reported |
| 2022-09-30 | (m) | $2.91B | $21.59M | $287.24M | $8.73M | (m) | 0.74% | 32.91× | Reported |
| 2022-06-30 | (m) | $2.81B | $20.77M | $279.27M | $8.33M | (m) | 0.74% | 33.53× | Reported |
| 2022-03-31 | (m) | $2.71B | $19.79M | $265.90M | $7.28M | (m) | 0.73% | 36.54× | Reported |
| 2021-12-31 | (m) | $2.63B | $18.68M | $260.46M | $6.85M | (m) | 0.71% | 38.03× | Reported |
| 2021-09-30 | (m) | $2.56B | $17.36M | $250.71M | $6.65M | (m) | 0.68% | 37.71× | Reported |
| 2021-06-30 | (m) | $2.49B | $16.45M | $239.46M | $6.68M | (m) | 0.66% | 35.85× | Reported |
| 2021-03-31 | (m) | $2.44B | $15.34M | $230.04M | $7.34M | (m) | 0.63% | 31.35× | Reported |
| 2020-12-31 | (m) | $2.40B | $14.52M | $223.16M | $9.36M | (m) | 0.60% | 23.84× | Reported |
| 2020-09-30 | (m) | $2.33B | $14.04M | $206.99M | $11.85M | (m) | 0.60% | 17.47× | Reported |
| 2020-06-30 | (m) | $2.25B | $12.70M | $182.72M | $14.01M | (m) | 0.57% | 13.04× | Reported |
| 2020-03-31 | (m) | $2.15B | $12.10M | $156.02M | $15.65M | (m) | 0.56% | 9.97× | Reported |
| 2019-12-31 | (m) | $2.04B | $11.32M | $129.18M | $15.66M | (m) | 0.56% | 8.25× | Reported |
| 2019-09-30 | (m) | $2.26B | $11.93M | $149.04M | $15.22M | (m) | 0.53% | 9.79× | Reported |
| 2019-06-30 | (m) | $2.18B | $11.76M | $139.38M | $15.31M | (m) | 0.54% | 9.10× | Reported |
| 2019-03-31 | (m) | $2.10B | $10.98M | $133.31M | $15.24M | (m) | 0.52% | 8.75× | Reported |
| 2018-12-31 | (m) | $2.04B | $10.34M | $128.49M | $15.18M | (m) | 0.51% | 8.46× | Reported |
| 2018-09-30 | (m) | (m) | $10.58M | $120.18M | $15.07M | (m) | (m) | 7.98× | Reported |
| 2018-06-30 | (m) | (m) | $9.92M | $116.46M | $14.60M | (m) | (m) | 7.98× | Reported |
| 2018-03-31 | (m) | (m) | $9.78M | $106.71M | $13.78M | (m) | (m) | 7.74× | Reported |
| 2017-12-31 | (m) | (m) | $9.70M | $81.28M | $13.62M | (m) | (m) | 5.97× | Reported |
| 2017-09-30 | (m) | (m) | $8.95M | $90.83M | $12.20M | (m) | (m) | 7.44× | Reported |
| 2017-06-30 | (m) | (m) | $9.04M | $85.31M | $10.82M | (m) | (m) | 7.89× | Reported |
| 2017-03-31 | (m) | (m) | $9.44M | $83.08M | $9.21M | (m) | (m) | 9.02× | Reported |
| 2016-12-31 | (m) | (m) | $9.10M | $91.85M | $7.14M | (m) | (m) | 12.87× | Reported |
| 2016-09-30 | (m) | (m) | $8.64M | $80.50M | $5.74M | (m) | (m) | 14.01× | Reported |
| 2016-06-30 | (m) | (m) | $8.12M | $82.05M | $4.41M | (m) | (m) | 18.60× | Reported |
| 2016-03-31 | (m) | (m) | $7.07M | $84.22M | $3.53M | (m) | (m) | 23.85× | Reported |
| 2015-12-31 | (m) | (m) | $6.68M | $93.08M | $2.83M | (m) | (m) | 32.91× | Reported |
| 2015-09-30 | (m) | (m) | $6.33M | $88.39M | $2.52M | (m) | (m) | 35.06× | Reported |
| 2015-06-30 | (m) | (m) | $6.03M | $82.09M | $2.13M | (m) | (m) | 38.61× | Reported |
| 2015-03-31 | (m) | (m) | $5.50M | $73.75M | $10.28M | (m) | (m) | 7.17× | Reported |
| 2014-12-31 | (m) | (m) | $5.19M | $72.92M | $12.98M | (m) | (m) | 5.62× | Reported |
| 2014-09-30 | (m) | (m) | $5.28M | $78.40M | $15.84M | (m) | (m) | 4.95× | Reported |
| 2014-06-30 | (m) | (m) | $4.84M | $83.39M | $18.61M | (m) | (m) | 4.48× | Reported |
| 2014-03-31 | (m) | (m) | $4.59M | $93.04M | $13.04M | (m) | (m) | 7.14× | Reported |
| 2013-12-31 | (m) | (m) | $4.40M | $57.94M | $12.79M | (m) | (m) | 4.53× | Reported |
| 2013-09-30 | (m) | (m) | $3.83M | $38.55M | $12.54M | (m) | (m) | 3.07× | Reported |
| 2013-06-30 | (m) | (m) | $3.71M | $41.77M | $12.45M | (m) | (m) | 3.36× | Reported |
| 2013-03-31 | (m) | (m) | $3.54M | $41.81M | $12.42M | (m) | (m) | 3.37× | Reported |
| 2012-12-31 | (m) | (m) | $3.38M | $76.05M | $12.23M | (m) | (m) | 6.22× | Reported |
| 2012-09-30 | (m) | (m) | $3.23M | $89.12M | $12.12M | (m) | (m) | 7.35× | Reported |
| 2012-06-30 | (m) | (m) | $3.29M | $89.42M | $14.35M | (m) | (m) | 6.23× | Reported |
| 2012-03-31 | (m) | (m) | $3.36M | $90.37M | $13.98M | (m) | (m) | 6.47× | Reported |
| 2011-12-31 | (m) | (m) | $3.36M | $90.70M | $13.78M | (m) | (m) | 6.58× | Reported |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | (m) | $2.90M | $75.65M | $9.12M | (m) | (m) | 8.29× | Reported |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | (m) | $2.33M | $58.94M | $5.69M | (m) | (m) | 10.36× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACS Group, Inc. (PACS) | United States | $6.566B | 25.08 |
| NATIONAL HEALTHCARE CORP (NHC) | United States | $3.473B | 23.65 |